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Abstract: One of the key drivers for the emergence and spread of antimicrobial resistance (AMR) is 
non-prudent antibiotic (AB) use, which results in selection pressure towards relevant bacteria. 
Community pharmacists have pivotal roles in facilitating the prudent use of ABs that have been 
demonstrated by several studies worldwide. The aim of our present study was to evaluate the 
knowledge, attitude and practice of community pharmacists related to AB use and infectious 
diseases in Hungary. A descriptive cross-sectional survey was performed among community 
pharmacists in Hungary with the use of an anonymous, structured and pilot-tested questionnaire. 
Data collection ran between January 2016 and January 2018; n = 339 community pharmacists 
nationwide were approached with our questionnaire, out of which 192 filled out our survey. 
Hungarian pharmacists have appropriate knowledge regarding ABs and antimicrobial therapy, and 
they realize the public health impact of the growing AMR. Twenty-five percent of participants 
admitted to giving out non-prescription ABs at least once in the last year. The age and presence of 
board-certified specializations were shown to be significant factors of self-perceived knowledge and 
professional attitudes. Educational strategies and interventions specifically aimed at focusing on 
identified shortcomings and changing certain attitudes could substantially improve AB dispensing 
and AB use, in addition to minimizing resistance. 
Keywords: community pharmacists; antibiotics; non-prescription; dispensing; knowledge; 
attitudes; practice; responsibility 
 
1. Introduction 
Since the end of the 20th century, antibiotics have started to lose their efficacy. Due to the rapid 
emergence of antibiotic (AB)-resistant bacteria (especially in Gram-negatives [1,2]) and a dwindling 
AB pipeline (principally drugs that would be useful in primary care [3,4]), the therapeutic 
armamentarium of physicians has narrowed considerably [5–7]. Multidrug-resistant (MDR) bacteria 
are associated with prolonged hospital stays, decreased quality of life (QoL), additional costs for the 
healthcare infrastructure, and excess mortality [8–10]. In fact, in 2011, the World Health Organization 
(WHO) decided on antimicrobial resistance (AMR) (Combat Antimicrobial Resistance: No Action 
Today, No Cure Tomorrow’) as the theme for World Health Day (seventh of April), signifying the 
magnitude of this phenomenon and as being one of top three threats to humanity [11]. 
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All healthcare professionals (HCPs), including nurses, technicians, pharmacists and physicians, 
have a responsibility in their clinical practice in keeping ABs effective [12–18]. Around 90% of AB 
consumption in human medicine occurs in outpatient settings; therefore, it is imperative to 
administer these drugs only in cases where it is appropriate [19–21]. Community pharmacists (CPs) 
are medical professionals in the primary healthcare system whom are often termed as the “first and 
last” healthcare providers [22]. They have significant roles in medicine provision, primary 
prevention, patient education, lifestyle-advice and safety monitoring (e.g., pharmaco-vigilance 
studies) [23–25]. In addition, due to the over-exerted primary care infrastructure of many countries 
(including Hungary), they may be the first point-of-contact with the healthcare system for many 
patients. CPs have pivotal roles in facilitating the prudent use of ABs [23–25]. They are well placed 
enough to advise patients about the correct application of ABs, the importance of intake regularity or 
when to finish therapy, interactions with food or other medications, possible adverse events, and, 
most importantly, they can highlight the importance and consequences of AB misuse and the basics 
of antimicrobial resistance [23–26]. 
Qualitative and quantitative levels of AB-consumption vary greatly in different countries in 
Europe; however, a north-to-south and west-to-east gradient of higher consumption rates has been 
observed [27]. The quantitative AB-consumption rate of Hungary is on the lower end of the spectrum, 
though the proportion of broad-spectrum agents used is the highest among EU Member States 
[27,28]. Around 93% of ABs are obtained from community pharmacies in Hungary (based on the 
results of the recent Eurobarometer report) [28]; however, a recent study demonstrated that ~2% of 
ABs in the country are from non-prescription sources and that non-prescription AB-sales have tripled 
over the last decade [29]. Additionally, a recent study in Hungary showed that a lack of primary care 
availability (which is a developing problem) leads to the over-prescription of ABs [30]. To the best of 
our knowledge, there has not been a single study to comprehensively assess the attitudes of 
community pharmacists related to their roles in prudent AB use in Hungary. The aim of our study 
was to evaluate the Knowledge, Attitude and Practice of community Pharmacists related to 
Antibiotic use and infectious diseases in Hungary (or KAPPhA-HU Study). 
2. Results 
2.1. Demographic Characteristics 
At the time of the study, n = 5575 CPs (4566 full-time and 1027 part-time or as substitute 
pharmacists) were employed in Hungary. A total of 339 CPs nationwide were approached with our 
questionnaire during post-gradual training sessions at three different institutions throughout 
Hungary, out of which a total of 195 CPs chose to participate in our survey (corresponding to a 
response rate of 57.5%). Three respondents (1.5%) were excluded due to incompletely filled out 
questionnaires; therefore, n = 192 were included in the final analysis. The majority of the respondents 
were from the Csongrád (41.1%), Pest (19.3%) and Bács-Kiskun (17.2%) counties, and there were no 
participants in five out the nineteen counties in Hungary (Figure 1). Out of the 192 participants, 69.8% 
(n = 134) were female and 41.1% were over 35 years of age (Table 1). The median age of the 
respondents was 30.5 years (average: 36.0 ± 11.7; range: 24–76 years), with younger participants in 
higher proportion (24–35 years: 58.9%). Almost two-thirds of pharmacists did not have a 
specialization, while 34.4% of respondents were board-certified pharmaceutical specialists (BCSPs); 
most of the specialized degrees concerned pharmacy operation and management (60 out of 66) (Table 
1). 
Table 1. Demographic characteristics of the participants. 
Characteristics % (n=) 
Gender   
Female 69.8% (n = 134) 
Male 30.2% (n = 58) 
Age   
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24–35 years 58.9% (n = 113) 
36–50 years 27.1% (n = 52) 
over 50 years 14.0% (n = 27) 
Board-Certified specializations    
No specializations (Pharm.D. only) 65.6% (n = 126) 
BCPS (Pharm.D. and specialization)  
Specializations represented: 34.4% (n = 66) 
Pharmacy operation and management 31.4% (n = 60) 
Pharmacology, pharmacotherapy 1.0% (n = 2) 
Pharmaceutical care 1.0% (n = 2) 
Phytotherapy 1.0% (n = 2) 
Pharm.D.: Doctor of Pharmacy, BCPS: board-certified pharmaceutical specialist. 
 
Figure 1. Geographical distribution of participants (n = 192) in the different counties in Hungary. 
2.2. Self-Perceived Knowledge-Level of CPs Regarding ABs and Infectious Diseases 
In the questions related to self-perceived knowledge (QK1–QK3 [questions related to 
knowledge], presented in Table 2.), the respondents received one point for each ‘true’ answer, totaling 
between 0 and 3 points. The average number of points during the analysis was 2.27 ± 0.86 (3.6%, 
16.7%, 28.6% and 51.1% of respondents received 0, 1, 2 and 3 points, respectively). While most of the 
CPs (>90%) considered their knowledge on AB therapy appropriate, this ratio decreased considerably 
when the same question was asked regarding the knowledge related to medical microbiology and 
infectious disease-epidemiology (70.8%) or bacterial resistance mechanisms (67.2%). 
Table 2. Questions regarding self-perceived knowledge of CPs 
 
True  
% (n=) 
False  
% (n=) 
Don’t Know/  
Uncertain  
% (n=) 
QK1 My knowledge regarding the 
pharmacological aspects of antibiotic therapy are 
appropriate. 
90.1% (n = 173) 2.1%  
(n = 4) 
7.8%  
(n = 15) 
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QK2 My knowledge regarding the 
pathomechanism and prevention of infectious 
diseases are appropriate. 
70.8%  
(n = 136) 
12.5%  
(n = 24) 
16.7%  
(n = 32) 
QK3 My knowledge regarding bacterial 
resistance are appropriate. 
67.2%  
(n = 129) 
12.0%  
(n = 23) 
20.8%  
(n = 40) 
2.3. AB Utilization 
The participants were asked to assess the AB utilization (QU1 [questions about AB utilization]) 
and the ratio of AB prescriptions on a pre-determined percentage scale as compared to the total 
prescription drug traffic in their respective pharmacies at which they are currently employed; the 
results are presented in Table 3. Individual pharmacies may significantly differ in the number, 
however, and, based on the estimations of the majority of respondents, around 5%–20% of 
prescriptions are for ABs (according to 65.3% of respondents). 
Table 3. Ratio of antibiotic (AB) prescriptions compared to total prescription drug traffic of given 
pharmacies, according to respondents’ assessment (QU1). 
0%–5.0% 9.9% 
5.1%–10.0% 24.5% 
10.1%–15.0% 21.5% 
15.1%–20.0% 19.3% 
20.1%–25.0% 12.5% 
more than 25.0% 12.5% 
2.4. Theoretical Attitude 
The theoretical attitudes of CPs were assessed by using eight questions (QTA1–QTA8) (Table 4). 
All respondents (100%) agreed that the inappropriate use of ABs is an issue in healthcare (QTA1). In 
another question, the opinions of the respondents were asked on the practice of other colleagues (the 
statement was “I believe that it is problematic that there are pharmacists who dispense antibiotics 
when the patients request them without a prescription,” QTA2); 87.0% (n = 167) respondents chose 
“True,” while 5.2% (n = 10) and 7.8% (n = 15) chose “False” and “I don’t know/Unsure” of the answer, 
respectively. From QTA3, the distribution of the responses to individual questions are presented in 
Table 4. Opinions about AB funding policy were divisive, as 27% of the pharmacist disagreed, 47.4% 
agreed, and 28.6% were unsure (QTA3); 93.7% of the respondents agreed that ABs are medicines of 
special importance (QTA4); 77% of the respondents were aware that inappropriate AB therapy causes 
significant surplus health costs, but 18.8% did not know this (QTA6); 92.7% agreed that university 
education should be more prominent about ABs (QTA7); and 79.1% of the pharmacists had the 
proper knowledge about the fact that the use of ABs in animal husbandry as growth promoters is just 
as important in the development of bacterial resistance, as their inappropriate 
prescription/consumption in health care, but 20.8% had no idea or disagreed with the fact (QTA8). 
2.5. Practical Attitude 
When asking about non-prescription AB-sales, respondents were classified as “low-risk” or 
“high-risk” pharmacists during analyses; 74.0% of CPs stated that they had never given out ABs 
without a prescription of a physician (QPA1) (Table 4) (“low-risk pharmacists,” excluding dispensing 
to other healthcare-professionals in exchange to presenting relevant professional licenses). In 
contrast, 21.9% of participants admitted to giving out non-prescription ABs at least once, while 4.1% 
had given out ABs at least five times in the last 12 months (“high-risk pharmacists”). Because 
pharmacists often get feedback from patients, they can evaluate their successfulness after giving 
advice, and 79.2% of them reported that patients happily accepted the counsels (QPA2). Positive 
reaction can further motivate a pharmacist in their everyday work. Quite a big proportion, 85.4% of 
the respondents felt obligated to inform those patients who requested ABs without perception of 
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their risk, though 12% believed the opposite (QPA3). The majority of pharmacists (85.9%) perceived 
that patients enter a pharmacy with a lack information and what should have been given by 
physicians previously; therefore, pharmacists need to set more time for patient education (QPA4). 
Pure practical competency was measured by the percentage of pharmacists who recommend 
probiotics and who detail the proper use of ABs for patients purchasing prescribed ABs, which had 
very high response rates, with 92.2% and 98%, respectively (QPA6 and QPA7). 
2.6. Attitude Towards Prevention 
The majority of pharmacists (88.6%) realized that the media does not devote enough energy to 
disseminate information on infectious diseases (QPr1) (Table 4). It seems from the answers given to 
the questions studying the attitudes of respondents regarding their patient educator roles that there 
is an agreement and a readiness among CPs, as more than a 90% agreement was measured for 
QPrA2–QPrA4 question. Generally, they believed in the power of patient education, that they can 
influence the patients’ approaches to infectious diseases, and that they need to provide lifestyle 
advice as well. Additionally, a big proportion of pharmacists (79.1%) felt that the proper use of ABs 
would be greater if pharmacists had time to perform their pharmacological care duties (QPrA5). 
2.7. Professional Attitude and Role Expansion 
The pharmacists were asked about potential expansion of their roles in the prevention of 
infectious diseases, the therapy of infectious diseases and their pharmaceutical profession overall 
(QPh1–QPh3) (Table 4); 46.4% of respondents were against the idea or was unsure about therapeutic 
decisions on uncomplicated infections (e.g., urinary tract infections and bacterial tonsillitis), while 
60.5% were against pharmacists in the management and administration of vaccinations (respondents 
without a specialty and >35 years of age were more likely to have a negative attitude; p = 0.011 and p 
= 0.013, respectively). However, 95.3% of the respondents stated that medicine-related counseling by 
CPs is just as important as the physician’s recommendations. A significant correlation was found 
between the self-perceived knowledge of CPs and their age (lower number of points if ≥35 years of 
age; p = 0.026) and specialization (board-certified pharmaceutical specialists (BCPSs) had a higher 
number of points; p = 0.048). Respondents with no specialization (p = 0.011) and over 35 years of age 
(p = 0.013) were more frequently high-risk pharmacists among the surveyed population. Of note, 
responses to QPA5 were especially daunting, as 43.8% admitted that the temperament of patients 
influences their everyday dispensing practice; this phenomenon was more prominent in pharmacists 
without specialty training (p = 0.002) and respondents ≤35 years if age (p = 0.009). 
2.8. Correlational Analysis between Self-Perceived Knowledge and Certain Attitudes 
The results of a correlational analysis of responses pertaining to theoretical–practical–preventive 
attitudes are shown in Supplementary Tables S2–S4. Self-perceived knowledge showed very few 
significant and weak correlations with theoretical, practical or preventive attitudes (Supplementary 
Table S2). Proper knowledge about the pathomechanisms and preventions of infectious diseases 
went together with the higher motivation to get to know new ABs and the proper practice of the less 
likely dispensing of ABs without a prescription; however, this knowledge was negatively correlated 
with a recognition of the poor public information of the media about infectious diseases, and it was 
less likely to be believed that pharmacists can form a patients’ approach about infectious diseases. 
Proper knowledge regarding bacterial resistance came along with the appropriate theoretical and 
practical attitudes of not dispensing ABs without a prescription and more likely providing lifestyle 
advice in addition to other recommendations. 
All measured items of the theoretical attitude were positively and significantly associated to 
several items of the practical attitude (Supplementary Table S3), with an especially strong association 
to better acquaintance with new ABs, which resulted in the CPs less often dispensing ABs without a 
prescription; with more acceptable pharmaceutical advice; with patient education when requiring 
ABs without prescription; or with more detailed advice about the proper use of ABs. It could be also 
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seen from the correlational coefficients that any improvement in theoretical knowledge could 
eventually lead to the more frequent—and hopefully efficient—informing and educating a patient 
who wants to access to AB without medical prescription. However, better theoretical knowledge did 
not influence the temptations caused by the patients’ behavior/personality and did not improve the 
recommendation frequency of probiotics. 
A better theoretical attitude positively and significantly correlated with good preventive 
attitudes, as well (Supplementary Table S3). The attitudes were particularly strong in the areas of the 
awareness of the fact that if they themselves or other pharmacists dispensed an AB without 
prescription is a problem, knowing the fact that animal husbandry has also a role in AB resistance 
called for the preventive attitude of understanding the efficiency of patient education and 
pharmacists in the prevention of infectious diseases, and offering healthy lifestyle recommendations 
as a must. Only appreciating the role of media in the prevention of infectious diseases was 
independent form the level of theoretical attitude. 
An improved preventive attitude was related to a better practical attitude in general 
(Supplementary Table S4). In the preventive domain, the confident belief that pharmacists could 
really form the patients’ attitude toward infectious diseases positively affected those practical 
behaviors, as resisting the patients’ temperament when making decisions in dispensing, when giving 
acceptable advice, or when educating the patients who ask for AB without prescription. This latter, 
was positively influenced by other preventive attitudes, as well, like understanding the positive role 
of patient education or with the highest correlational coefficient and with the strongest relation by 
accepting the additional task of a pharmacist to provide recommendation on a healthy lifestyle. 
Interestingly, some of the appropriate practical attitudes went together with the over-evaluation of 
the role of media (negative correlation) in raising public awareness about infectious diseases. 
Table 4. Responses of CPs regarding attitudes and professional responsibility. 
Questions Regarding Attitudes and 
Professional Responsibility (QA) 
SD D 
U/DK 
A SA 
Disagree Agree 
Theoretical attitude 
QTA3 I agree with the current 
funding policy of the National Institute 
of Health Insurance Fund Management 
regarding antibiotics (detailed in 
Decree No.32/2004 (IV.26.) Regulation 
by Ministry of Health, Social and 
Family Affairs about health insurance 
supported pharmaceuticals and the 
amount of subsidy). 
2.1%  
(n = 4) 
21.9%  
(n = 42) 
28.6%  
(n = 55) 
44.3%  
(n = 85) 
3.1%  
(n = 6) 
QTA4 Antibiotics are medicines of 
special importance. 
2.1%  
(n = 4) 
3.6%  
(n = 7) 
0.5%  
(n = 1) 
45.3%  
(n = 87) 
48.4%  
(n = 93) 
QTA5 I may be held responsible for the 
non-prescription dispensing of 
antibiotics, as this is a public health 
risk. 
0.5%  
(n = 1) 
12.5%  
(n = 24) 
2.1%  
(n = 4) 
43.8%  
(n = 84) 
41.1%  
(n = 79) 
QTA6 Inappropriate antibiotic therapy 
does not cause significant surplus 
health costs on an annual basis. 
41.1%  
(n = 79) 
35.9%  
(n = 69) 
4.2%  
(n = 8) 
12.5%  
(n = 24) 
6.3%  
(n = 12) 
QTA7 Education regarding antibiotics 
and antibiotic resistance should be 
more prominent during university 
training. 
1.0%  
(n = 2) 
5.2%  
(n = 10) 
1.0%  
(n = 2) 
35.9%  
(n = 69) 
56.8%  
(n = 109) 
QTA8 The use of antibiotics in animal 
husbandry as growth promoters is just 
0%  
(n = 0) 
8.3%  
(n = 16) 
12.5%  
(n = 24) 
40.6%  
(n = 78) 
38.5%  
(n = 74) 
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as important (or more important) in 
the development of bacterial resistance 
as their inappropriate 
prescription/consumption in health 
care. 
QTA9 I consider it important to 
become acquainted with the antibiotics 
of the current drug pool and those 
newly licensed on the market. 
0%  
(n = 0) 
5.2%  
(n = 10) 
1.0%  
(n = 2) 
31.3%  
(n = 60) 
62.5%  
(n = 120) 
Practical attitude 
QPA2 Patients are mostly receptive of 
my advice during dispensing, they 
welcome it. 
3.1%  
(n = 6) 
12.5%  
(n = 24) 
5.2% 
(n = 10) 
64.1%  
(n = 123) 
15.1%  
(n = 29) 
QPA3 For patients requesting 
antibiotics without a prescription and 
are probably not in need of antibiotic 
therapy, I feel obligated to inform and 
educate them. 
0%  
(n = 0) 
12.0%  
(n = 23) 
2.6%  
(n = 5) 
53.1%  
(n = 102) 
32.3%  
(n = 62) 
QPA4 There are several occasions 
when more time is needed to educate 
patients because doctors have not done 
this properly. 
0%  
(n = 0) 
6.3%  
(n = 12) 
7.8%  
(n = 15) 
52.6%  
(n = 101) 
33.3%  
(n = 64) 
QPA5 The personality and behavior of 
patients significantly influences my 
dispensing practices. 
17.2%  
(n = 33) 
34.4%  
(n = 66) 
4.7%  
(n = 9) 
29.2%  
(n = 56) 
14.6%  
(n = 28) 
QPA6 I offer probiotics for the patients 
purchasing a prescribed antibiotic. 
0%  
(n = 0) 
7.3%  
(n = 14) 
0.5%  
(n = 1) 
46.4%  
(n = 89) 
45.8%  
(n = 88) 
QPA7 I detail the proper use of 
antibiotics when counselling the 
patient. 
0%  
(n = 0) 
2.0%  
(n = 4) 
0%  
(n = 0) 
36.5%  
(n = 70) 
61.5%  
(n = 118) 
Preventive attitude 
QPrA1 The media devotes enough 
energy to disseminate information on 
infectious diseases. 
37.0%  
(n = 71) 
51.6%  
(n = 99) 
2.6%  
(n = 5) 
8.9%  
(n = 17) 
0%  
(n = 0) 
QPrA2 Appropriate patient education 
would effectively reduce the incidence 
of infectious diseases. 
0%  
(n = 0) 
6.3%  
(n = 12) 
1.6%  
(n = 3) 
56.8%  
(n = 109) 
35.4%  
(n = 68) 
QPrA3 As I am in direct contact with 
patients on a daily basis, I have the 
opportunity to influence their approach 
to infectious diseases. 
0.5%  
(n = 1) 
6.3%  
(n = 12) 
1.6%  
(n = 3) 
65.6%  
(n = 126) 
26.0%  
(n = 50) 
QPrA4 During my work as a 
pharmacist, I not only have to make 
therapeutic decisions about acute 
infection, but I also have to provide 
lifestyle advice to the patient. 
0%  
(n = 0) 
2.6%  
(n = 5) 
4.7%  
(n = 9) 
53.1%  
(n = 102) 
39.6%  
(n = 76) 
QPrA5 Proper use of antibiotics would 
be greater if pharmacists had time to 
perform their pharmacological care 
duties. 
0.5%  
(n = 1) 
15.6%  
(n = 30) 
4.7%  
(n = 9) 
53.1%  
(n = 102) 
26.0%  
(n = 50) 
Professional attitude 
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QPh1 Pharmacists should be 
authorized to perform the task of 
selecting the therapy in case of proven 
uncomplicated infections. 
8.3%  
(n = 16) 
33.9%  
(n = 65) 
4.2%  
(n = 8) 
39.1%  
(n = 75) 
14.6%  
(n = 28) 
QPh2 After appropriate training, 
pharmacists could also perform the task 
of administering vaccines. 
21.4%  
(n = 41) 
32.8%  
(n = 63) 
6.3%  
(n = 12) 
30.2%  
(n = 58) 
9.4%  
(n = 18) 
QPh3 Medicine-related counseling of 
community pharmacists is just as 
important as the physician’s 
recommendations. 
2.6%  
(n = 5) 
4.2%  
(n = 8) 
0%  
(n = 0) 
33.9%  
(n = 65) 
59.4%  
(n = 114) 
Abbreviations: A: agree; D: disagree; U/DK: don’t know/unsure of the answer; SA: strongly agree; 
SD: strongly disagree; QTA: question related to theoretical attitude; QPA: question related to 
practical attitude; QPrA: question related to preventive attitude; and QPh: question related to 
pharmaceutical profession. 
3. Discussion 
The present nationwide survey aimed to explore CPs’ knowledge, attitude and practice 
regarding ABs and infectious diseases, as well as their relationship with the dimension of professional 
responsibility related to the spread of AB resistance in Hungary. Our results showed that respondents 
≥35 years of age and pharmacists without specialization were less confident about their roles and 
knowledge regarding ABs and infectious diseases. The majority of respondents had a high level of 
theoretical knowledge regarding antimicrobials and resistance. The vast majority (87%) of our 
interviewed pharmacists agreed that other pharmacists should not dispense ABs without a medical 
prescription, while almost the same amount of them (84.9%) evaluated themselves, as well, as causing 
public health problem if they do this malpractice. Despite this, 26% of the interviewed pharmacists 
confessed that they had already dispensed non-prescribed ABs. We found that almost half of the 
pharmacists perceived that the patients’ personality and behaviors could influence their dispensing 
habits. According to the correlational analysis, the manipulating nature of the patients’ temperament 
on dispensing pattern could not be influenced by any theoretical or preventive item, although 
pharmacists’ knowledge and attitude were strongly associated with dispensing a non-prescribed AB. 
Around half of the respondents showed resistance towards the potential expansion of the 
professional role of CPs. 
The roles of healthcare professionals in the fight against AB resistance were emphasized in 
multiple reports by the WHO. The requirements on the knowledge-level of healthcare professionals 
were re-iterated in the ‘Competency framework for health worker’s education and training on 
antimicrobial resistance,’ which details specific points of competence for all healthcare professionals 
working in different settings [31]. The most recent report was published by the European Centre for 
Disease Prevention and Control [ECDC], which (similarly to the present study) aimed to assess 
knowledge, attitudes and behaviors on ABs, AB use and AMR in the European Union/European 
Economic Area [EU/EEA] [32]; out of the 18,365 HCPs in different healthcare settings, 17.7% were 
pharmacists. In the report, most (89%) respondents agreed that their practice of the 
prescribing/dispensing/administering of ABs directly affected the emergence and spread of AB-
resistant bacteria; in addition, knowledge on ABs was measured with seven questions, and 
Hungarian HCPs were among the EU countries where less than 50% of respondents answered all 
questions correctly [32]. 
3.1. Knowledge-Level of CPs 
Considering the theoretical knowledge, every respondent in our study unanimously agreed that 
inappropriate AB use is a major health problem, and almost everyone considered ABs as medicines 
of special importance. In a Portuguese survey, 100% of pharmacists declared that AB resistance is an 
important public health issue [33]. However, Australian hospital pharmacists reported ambivalent 
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views towards the significance of AB resistance and regarded optimizing AB use as a low priority 
[34]. In our study, 18.8% of the respondents thought that AB misuse could not cause surplus health 
cost, this group comprised 30.4% of the Albanian pharmacists who were interviewed in a previous 
study [35]. According to our results, the majority of pharmacists knew that AB misuse in animal care 
can also contribute to AB resistance. The external responsibility of veterinarians has also been 
perceived by other studies [16,33]. 
3.2. Non-Prescription AB Use 
Non-prescription (OTC) AB use and antibiotic self-medication (SMA) is one of the main factors 
in the irrational use of ABs and the development of MDR bacteria, so controlling AB use may present 
as a viable means of intervention [36–38]. Our results (e.g., 26% of the interviewed had dispensed 
non-prescribed ABs) are comparable with those found by Vazquez-Lago et al., as they found that 
5%–20% of the pharmacists dispensed non-prescribed ABs [39]. A very similar proportion of the 
Albanian pharmacists, 89%, thought that ABs should not be given out without a prescription [35]. 
Other European studies have found that pharmacist occasionally dispense non-prescribed ABs 
[40,41]; however, there are big differences within Europe, e.g., in Spain, though the unlawful 
dispensing of ABs without a medical prescription is a common practice, as 65% of the responding 
pharmacist reported this bad practical attitude. This malpractice has not been correlated with age, 
gender, or years of professional experience [42]. In a representative Portuguese study, 49% of the 
pharmacy workers had a propensity to dispense ABs without medical prescription if the patient was 
known to the pharmacist [33]. The finding of another Portuguese study revealed the same to what 
we found, namely that elderly generations were more likely have dispensed an unprescribed AB [43]. 
This may be because elderly pharmacists realize the impact of sales levels on their salaries, and they 
feel a priority to sell the AB. 
The main reasons for the malpractice of non-prescription AB-dispensing were summarized by 
Vazquez-Lago et al. [39]: the study group had defined reasons such as economic/patient-specific (a.: 
pressure from patients to have their complaints rapidly resolved; b.: fear of losing loyal customers, 
especially in smaller towns; c.: fear of rejection by common people with not meet expectations; and 
d.: pressures from pharmacy owners), internal/pharmacist-specific (bad habits during dispensing 
and a lack of continuous professional development) and external (indifference of physicians 
regarding patient follow-up, a lack of communication, no enforcement on the part of the authorities). 
These findings have been reinforced by several other publications [33–38,40–42]. Recently, 
pharmacists have tended to shift the responsibility of the problem of antimicrobial resistance to 
external sources, such as patients, physicians, other pharmacies and veterinarians [33,43,44]. 
Patient demand was reported by CPs several times as being one of the greatest barriers to 
improve AB utilization [45]. In developed countries, like Hungary, the main reason for OTC ABs is 
patient demand and a fear of losing customers of the business. This is proven by our results, as one 
of the most remarkable findings was that almost half of the pharmacists perceived that the patients’ 
temperament could influence their dispensing habits, especially those with lack of experience and 
those who were less qualified. A Portuguese survey identified complacency as the primary factor 
(patient has difficulty/shortage of time or money in obtaining medical care or they can acquire in 
another pharmacy [33]). The pressure of losing patients because of competition between pharmacies 
could be minimized by changes in the healthcare-system, just like in the UK or Australia, where 
patients after visiting their allocated general practitioners, can get medicines dispensed from an 
adjacent pharmacy [46]. Maybe, if pharmacists were more aware that dispensing ABs is part of their 
social responsibility, just like in the UK [47], the status of Sweden could be reached, where the public 
trusts HCPs more if they do not prescribe ABs. Thus, it should be highlighted that CPs (especially in 
countries where their roles do not include prescribing/de-prescribing) alone are unable to promote 
appropriate AB use if GPs still supply patients with AB-prescriptions in inappropriate situations 
[33,40–43,46]. Of local relevance, a study by Gajdács et al. regarding the attitudes of GPs in the 
Csongrád county of Hungary found that around 80% of GPs were satisfied with their knowledge 
regarding infectious ailments and AB therapy, while only 48% were confident about their knowledge 
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on AB-resistance; in addition, 25% of respondents stated that the personality and behavior of patients 
significantly influenced their prescribing practices [48]. However, along with our results, either any 
higher theoretical knowledge or any improved preventive view ended in one of the most important 
proactive practical behaviors of pharmacists, as they more likely educated those patients who were 
expected to have access ABs without a medical prescription. We found that pharmacists’ knowledge 
and attitude were associated with the dispensing of a non-prescribed AB. Zapata-Cachafeiro 
concluded the same; additionally, indifference, complacency, external responsibility and insufficient 
knowledge have all been identified as attitudes that increase the risk of this malpractice [42]. There 
have been promising results for reducing the prevalence of faulty dispensing, as it has been self-
reported by pharmacists that patients who insist on obtaining an AB have been able to understand 
and stop insisting, though only after they explained the consequences of unnecessary use [43]. 
3.3. Role of CPs in Patient Education 
Many strategies have been proposed to facilitate the prudent use of ABs in inpatient settings 
[49]. In contrast, stewardship practices are much less prevalent in outpatient medicine. Most 
strategies to improve prudent AB use emphasize the role of patient education (both by the use of 
banners and social media and by HCPs during visits to the physicians/pharmacies) [49]. According 
to international studies, doctors, pharmacists and nurses have been most frequently indicated as the 
most reliable sources of AB information [32]. Confirming this, the Special Eurobarometer on ABs 
(EBM 478) reported that in the last 12 months, 32% of respondents have taken ABs (33% in Hungary), 
and 22% of respondents had received advice from pharmacists on not taking ABs unnecessarily [28]. 
In the present study, almost 80% of respondents stated that a lack of time was to blame for inadequate 
patient education and prevention practices; the reason for this may be due to the over-exertion of 
these HCPs, as, based on projections of Hungarian National Healthcare Services Center, there would 
need to be 7500–8000 CPs employed for the unobjectionable provision of pharmaceuticals in primary 
care [50]. The present study revealed that the patient-educator role was very much emphasized by 
the Hungarian pharmacists, as, generally, they strongly trusted the power of patient education. 
Roque et al. also reported that all patients were advised by a pharmacist upon AB dispersion [33]. 
Everyday patient–pharmacist communication and pharmacist-involved public awareness campaigns 
have been proven to be efficient in several countries, e.g., antimicrobial consumption was successfully 
reduced with 60% by improved patient communication in a German campaign [51]. 
Professional pharmaceutical advice can really affect patients’ perceptions and attitude towards 
their illness and their perceived need for ABs. In a study done in London, it was revealed that those 
who received counselling from a CP displayed a better knowledge towards prudent AB usage than 
those who were exposed to an AB campaign [52]. This emphasizes the importance of pharmacists’ 
counselling on every AB prescription. However, for this, pharmacists must have the knowledge, 
attitude, self-confidence and communication skills to achieve this. If they believe that they can affect 
patients’ approach, they can more successfully acquire a good practical attitude. However, until 
pharmacists are perceived by the general population as “educated sellers” and their competencies 
are no longer underestimated by physicians, their confident standing by antimicrobial stewardship 
may be undermined [49,53]. A systematic review concluded that if pharmacists are involved in health 
promotion, then their reputation can improve [54]. 
There are several countries where physicians’ counselling practice is really poor or where, even 
if it appropriate, there are some topics related to infection prevention and control that are less likely 
to be counselled (food handling, household hygiene, proper coughing and hand-washing practices, 
and using hand sanitizer and antibacterial supplies) as physicians consider them less important in 
the prevention of antimicrobial resistance or they might expect that other health care professionals 
will do this. By our results, a very big proportion of respondents blamed physicians for insufficient 
patient education, and they sensed that they needed to expend surplus time to explain everything. 
Pharmacists’ negative views towards physicians are reinforced when they catch antimicrobial 
prescription errors, as, according to some reports, 19%–36% of prescriptions are illegible or 
incomplete [55]. This emphasizes the additional role of a pharmacist: a sentinel. There is evidence 
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that clearly shows the importance of pharmacists in supporting GPs to foster appropriate the 
prescribing practice of ABs. This means structured visits by clinical pharmacists that target GPs when 
the pharmacist is a therapeutic adviser, an academic detailer, a reviewer of medication prescription 
and feedback provider [48]. All in all, general physician–community pharmacist close collaborations 
are essential and can be effective, as was confirmed by Vervloet et al. [56]. In the UK, the position of 
an antimicrobial pharmacist was introduced to support GPs’ decisions in AB prescribing [48]. 
3.4. Potential Expansion of Professional Role of Pharmacists 
CPs were also surveyed regarding their potentially expanding professional role on 
administering vaccination and deciding on the pharmacotherapy of uncomplicated infections. 
Pharmacy-based influenza immunization services have been already running in England, Portugal, 
Belgium, Australia and some states of USA [24,25]. This could be a next step in involvement of 
pharmacists in direct patient care, and vaccination coverage has been proven to have been improved 
in these regions. There are some countries (Canada, New Zealand, UK) where pharmacists are legally 
allowed to prescribe antimicrobials in certain cutaneous or urinary tract infections, chlamydia or 
Lyme disease [57]. In USA, in the framework of collaborative practice agreement, pharmacists 
perform specific patient care functions, such as screening patients and prescribing antivirals in 
influenza season, immunizations, medication therapy management, and, when paired to a physician, 
implementing point-of-care tests and initiating appropriate therapy. Finally, this program has led to 
a more judicious use of antimicrobials in these areas [58]. In our present study, a significant portion 
of respondents were against the idea (>40% pro and >60% against), mainly among older HCPs. This 
may have been due to a variety of reasons: their inadequate training and competence level, their 
objections towards administering vaccines (technical aspects), their refusal of taking on additional 
responsibilities, and so on. However, the most probable reason was an external one, namely that the 
medical community (i.e., physicians) would not agree to such a change in the healthcare system in 
Hungary. This sentiment was verified by our previously mentioned study: while 72.3% of 
respondents believed that CPs have important roles in facilitating appropriate drug use, 77.1% of GPs 
objected to pharmacists making therapeutic decisions and administering vaccines [48]. Otherwise, 
the responding pharmacists stood by their competency and their importance in health care, as they 
evaluated their own counselling being equal to physicians’ instructions. 
3.5. Influence of Personal and Professional Characteristics 
While a correlation with age of the pharmacists seems logical (less time has elapsed since 
finishing training, and a decline in knowledge-level has been identified by many studies) [19–21], the 
correlation of roles and knowledge regarding ABs and infectious diseases with specialty training is 
less clear; most respondents had the “Pharmacy operation and management” specialty, which has 
been used as a prerequisite to become a Lead pharmacist in Hungary since 2015. The curriculum of 
the abovementioned training mainly involves managerial and economical competences, whilst topics 
of pharmacology and public health are not included; therefore it can be assumed that the acquisition 
of the specialty per se is not the reason for the better performance of the respondents; instead, their 
higher professional standing and confidence in their workplace may explain their better performance. 
Another possible explanation is that the importance of AB-resistance has taken center stage in the last 
10–15 years due to increased media attention; however, pharmacists finishing their Doctor of 
Pharmacy (Pharm.D.) training over 15–20 years ago may have heard limited amounts of information 
on the topic. Adequate knowledge itself does not guarantee proper practices. This situation is called 
as the “theory–practice gap,” and many reports have suggested that practice is mainly influenced by 
the attitudes of HCPs [59]. 
In our study, almost everyone stated that they had the proper level knowledge about AB 
therapy, but they were less likely to be familiar with the pathomechanisms of infectious diseases and 
bacterial resistance. The same findings have been reported by other surveys, where majority of the 
pharmacists have been found to have an understanding of the problem of AB resistance and its 
effect(s) on public health, but they were not found to have a full understanding of how AMR develops 
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and spreads [33,40–43,46]. According to our results, self-perceived knowledge on ABs and infectious 
diseases did not seem to be a good indicator of appropriate theoretical, practical or preventive 
attitude. Those who can realize their gaps in knowledge may have a good attitude towards proper 
AB use. An improved theoretical attitude was correlated to better practical and preventive attitude, 
and, vice versa, better preventive attitude was related to improved practical attitude. Even so, within 
the theoretical domain, getting acquainted with current and new ABs was the strongest influencer of 
a better practical attitude, which indirectly indicates that proper knowledge is indispensable for good 
attitude. Altogether, appropriately trained pharmacists are needed, and gaining a high level 
professional knowledge related to AB resistance at medical universities and strengthening the 
medical and pharmaceutical curricula have already been identified by several reports as important 
considerations for the future [24,32]. This was confirmed by our study, as almost all respondents 
agreed that university education should focus more on ABs. 
Our study concluded that there is a complex relationship between the knowledge, attitude and 
practice of pharmacists on AB dispensing and willingness for counselling. The theoretical framework 
of connections between the three items have been used several times and discussed in publications 
in regard to AB utilization among physicians and pharmacists [33,40–43,46]. Our results reinforce the 
results published by Liu et al., as they also found that the knowledge, attitude, and practice of 
physicians toward AB prescription are closely linked to each other; however, improving knowledge 
itself is not enough because it is not always associated with intentions to change behavior [60,61]. 
3.6. Limitations of the Study 
There are several limitations of this study that need to be addressed for transparency: (a.) There 
was a relatively low number of participants from the pool of practicing CPs (n = 192 vs. n = 5575); (b.) 
there were some counties in Hungary from which there were no participants in this study, so the 
findings may not represent the knowledge, attitude and practices of CPs in other parts of the country; 
(c.) the study sample was diverse in terms of participant’s age, years of experience, but >50% of 
pharmacists were 35 years old or younger, which may have resulted in a bias towards the opinions 
of younger healthcare-professionals; (d.) the questionnaire was self-administered, so data collection 
was prone to social desirability bias (tendency of respondents to choose answers that are socially 
acceptable instead of responses that mirror their true feelings or practices); (e.) during the survey, the 
knowledge of the relevant topics (AB therapy, infectious diseases, and resistance) was self-evaluated, 
but the correlation between the real knowledge and self-perceived knowledge was not tested; and (f.) 
the current survey could not measure the correlation between the practices of CPs with their 
attitudes—for the evaluation of this, simulated patient studies are needed [17]. Despite the mentioned 
limitations, some key concepts regarding CPs in Hungary have been identified. Furthermore, since 
the created novel survey instrument may facilitate the development of further studies. 
4. Materials and Methods 
4.1. Study Design, Questionnaire 
A descriptive cross-sectional survey was performed among CPs in Hungary by using an 
anonymous, structured and pilot-tested questionnaire. The methods that were used during sample 
size calculation are described in the Supplementary Section S1. 
An extensive literature review of similar surveys was conducted in the PubMed/MEDLINE 
database in order to identify potential questions for the development of the questionnaire that was 
used in this study. The content validation and internal consistency-assessment of the questionnaire 
are described in Supplementary Section S2. The final structured questionnaire consisted of 32 
questions that covered three major areas: Section I.: demographic characteristics (four items: age, sex, 
qualification level, and location of the pharmacy); Section II.: questions about self-perceived 
knowledge and practice related to the dispensing of ABs (seven items, including subjective beliefs 
related to knowledge levels, ratio of AB-prescriptions in the pharmacy of interest, and the non-
prescription dispensing of ABs) where the respondents had the option of choosing either percentages 
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or were given the options of ‘Yes,’ ‘No,’ and ‘I don’t know/Unsure about the answer’ to choose from; 
Section III.: questions regarding attitudes and personal responsibility in the curbing of AB resistance 
(twenty-one items, including theoretical, practical and preventive attitudes, as well as views towards 
the current and emerging roles of CPs in medical interventions and pharmaceutical care), where a 
five-point Likert-scale ranging from “strongly agree” to “strongly disagree” was used to measure the 
responses of the participants. However, different items, belonging to the same attitude, were mixed 
in the questionnaire, and, upon analysis, they were examined together. 
4.2. Data Collection and Statistical Analysis 
Data collection for the survey was running between January 2016 and January 2018. Participants 
were informed about the purpose, benefits, and risks of the study, and each participant provided 
written informed consent. Participants completed the questionnaires anonymously, and the surveys 
were collected afterwards. No renumeration or gifts were given to participants to facilitate their 
participation in the survey. Assistant pharmacists and pharmacy students fell under the exclusion 
criteria of the study. All questionnaires were checked manually, and questionnaires with >90% 
completion were included in the analysis. All the completed questionnaires were entered into Epi-
data version 3.1, and the data were exported to SPSS Statistics version 23.0 (IBM; Chicago, IL, USA) 
for data analysis. Descriptive statistics and univariate analysis were performed (Pearson’s Chi-
squared tests or Fisher’s exact tests were used when comparing proportions, while Student’s t-tests 
were utilized to assess the association between numerical values). During statistical analyses, the 
respondents were classified into two age groups (24–35 years and older than 35 years; see Section I. 
in the final instrument), and the self-perceived knowledge of the respondents on infectious diseases 
and ABs (see QK1-3 in Section II. of the final instrument) was expressed as a score of 0–3 for statistical 
evaluation (one point awarded for every “True” answer). To make the results more intelligible in the 
text and scoring, “strongly agree” or “agree” were classified as “agree” and “strongly disagree” or 
“disagree” were classified as “disagree.” 
To find a possible correlation between different attitudes, a correlational analysis was done. 
From the attitude questions, just the most important ones (excluding the opinions) and those whose 
answers were given on the same five-point Likert scale range were used for analysis. The chosen 
items are seen in Supplementary Table S2–S4. First, data were tested for normality by the 
Kolmogorov–Smirnov and Shapiro–Wilk tests. All parameters were skewed and not normally 
distributed, so nonparametric analyses were used. The strength of linear relationship between the 
four domains (appropriate theoretical, practical, preventive attitude and subjective knowledge level) 
was analyzed by the Spearman correlation coefficient. Two-tailed tests were utilized to assess 
significance. A difference with p  <  0.05 was considered statistically significance. 
4.3. Ethical Approval 
The survey was conducted in accordance with the Declaration of Helsinki and national and 
institutional ethical standards. Ethical approval for the study protocol was obtained from the Human 
Institutional and Regional Biomedical Research Ethics Committee, University of Szeged (registration 
number: 3688). 
5. Conclusions 
This is the first study in Hungary about the knowledge, attitude and practice of community 
pharmacists regarding antibiotic use and infectious diseases. Altogether, Hungarian pharmacists 
have appropriate knowledge regarding antibiotics and antimicrobial therapy, and they realize the 
public health impact of the growing antimicrobial resistance. Their theoretical, practical and 
preventive attitude is very positive. They consider the health promotion of infection prevention and 
control and patient education as very important aspects of the pharmaceutical work. The only 
malpractice identified was that a quarter of them were found to dispense antibiotics without a 
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medical prescription, although many of them are aware that this must not be done. Another 
remarkable result was the detection of the deep influencing role of patients on dispensing practice. 
Community pharmacists possess the opportunity (contact with prescribers and patients), 
commitment and capability (knowledge about medicines), all of which are key components for 
successful behavioral change of the patients towards rational antibiotic use. With further training, 
their motivation can be enhanced. An outstanding outcome of our survey was that half of the 
pharmacists disagreed with the possibility of expanding the role of pharmacists toward therapy 
selection or administering immunization. An improved theoretical attitude was interrelated to better 
practical and preventive attitudes. However, patient demand is not influenced by a high theoretical 
knowledge. Once the knowledge-levels and attitudes (which are modifiable factors) of community 
pharmacists regarding inappropriate AB use have been assessed, there will be a chance to design 
specific and focused interventions to encourage prudent antimicrobial use in an outpatient setting. 
On one hand, basic level-microbiology and pharmacotherapy-based educational interventions 
should be undertaken to reduce gaps of knowledge. On the other hand, educational interventions 
that target compliance with a professional code of ethics and attitude-change could also result in 
marked improvements in the dispensing habits of community pharmacists. Improving community 
pharmacists’ dispensing attitude and skills can be achieved by methods such as small group snapshot 
teaching, creative mnemonics like the “WWHAM” (Who is the patient, What are the symptoms, How 
long have the symptoms been present, Action taken, Medication being taken, and their experience) 
or “ASMETOD” (Age/appearance, Self or someone else, Medication, Extra medicines, Time 
persisting, History, Other symptoms, Danger symptoms) through the use of leaflets that facilitate 
self-care conversations with patients, mobile phone applications, and interactive antibiotic resistance 
maps. 
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